{"id":"levosimendan-infusion","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Hypotension"},{"rate":null,"effect":"Arrhythmias"},{"rate":null,"effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Levosimendan binds to cardiac troponin C and enhances the interaction between actin and myosin filaments, thereby increasing myocardial contractility. Simultaneously, it opens ATP-sensitive potassium channels in vascular smooth muscle, producing vasodilation and reducing cardiac afterload. This dual mechanism improves cardiac output while reducing myocardial oxygen demand.","oneSentence":"Levosimendan is a calcium sensitizer that increases the force of cardiac muscle contraction without increasing oxygen consumption, while also causing vasodilation through opening of ATP-sensitive potassium channels.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:34:00.662Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute decompensated heart failure"},{"name":"Cardiogenic shock"}]},"trialDetails":[{"nctId":"NCT07416331","phase":"","title":"Impact Of Using LevosemidanVersus DobutamineOn Right Ventricular Function In AdultPatients Undergoing Elective Valve Replacement Surgery","status":"COMPLETED","sponsor":"Helwan University","startDate":"2024-08-01","conditions":"Right Ventriculaire Dysfunction, Pulmonary Hypertension","enrollment":52},{"nctId":"NCT04158674","phase":"PHASE3","title":"Interest of Levosimendan in Reducing Weaning Failures of ExtraCorporeal Life Support - ECLS","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2020-02-24","conditions":"Acute Decompensated Heart Failure","enrollment":82},{"nctId":"NCT07105202","phase":"PHASE4","title":"Shorter Weaning From Invasive Ventilation With Levosimendan","status":"RECRUITING","sponsor":"Radboud University Medical Center","startDate":"2025-09-17","conditions":"Mechanical Ventilation, Weaning Failure","enrollment":250},{"nctId":"NCT07262723","phase":"PHASE2, PHASE3","title":"Levosimendan in Acute Decompensated Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Chittagong Medical College","startDate":"2025-12-01","conditions":"Acute Decompensated Heart Failure (ADHF)","enrollment":332},{"nctId":"NCT07186062","phase":"","title":"Clinical Outcomes of Levosimendan Versus Dobutamine Versus Milrinone in Cases With Acute Decompensated Heart Failure With Impaired Renal Function","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-06-01","conditions":"Acute Decompensated Heart Failure (ADHF), Cardiorenal Syndrome (CRS)","enrollment":60},{"nctId":"NCT05664191","phase":"PHASE2","title":"Levosimendan as Treatment of Aneurysmal SubArachnoid Haemorrhage","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-10-13","conditions":"Sub-arachnoid Haemorrhage","enrollment":30},{"nctId":"NCT03624010","phase":"PHASE2","title":"Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients","status":"COMPLETED","sponsor":"Tenax Therapeutics, Inc.","startDate":"2018-11-14","conditions":"Hypertension Pulmonary Secondary Heart Failure, Right Sided Heart Failure With Normal Ejection Fraction, Heart Failure With Normal Ejection Fraction","enrollment":20},{"nctId":"NCT04020263","phase":"PHASE3","title":"Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock","status":"RECRUITING","sponsor":"Pr Bruno LEVY","startDate":"2023-07-03","conditions":"Cardiogenic Shock","enrollment":610},{"nctId":"NCT04705337","phase":"PHASE4","title":"Levosimendan In Ambulatory Heart Failure Patients","status":"TERMINATED","sponsor":"Medical University of Bialystok","startDate":"2021-12-15","conditions":"Heart Failure New York Heart Association Class III, Heart Failure New York Heart Association Class IV, Heart Failure, Systolic","enrollment":70},{"nctId":"NCT04329624","phase":"PHASE3","title":"Effect Levosimendan Administration on Postoperative NT-proBNP in Cardiac Risk Patients","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2020-10-10","conditions":"Cardiovascular Risk Factor","enrollment":230},{"nctId":"NCT06478667","phase":"PHASE3","title":"The Role of Levosimendan as Inotropic Agent in Acute Aluminum Phosphide-induced Cardiotoxicity","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-12-20","conditions":"Acute Myocarditis","enrollment":50},{"nctId":"NCT04728932","phase":"PHASE3","title":"LEVOSIMENDAN to Facilitate Weaning From ECMO in Severe Cardiogenic Shock Patients","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-08-27","conditions":"Cardiogenic Shock, Extracorporeal Membrane Oxygenation Complication","enrollment":206},{"nctId":"NCT06784570","phase":"PHASE2","title":"Impact of Perioperative Levosimendan on Patients Undergoing Cardiac Surgery With Low Ejection Fraction","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2021-01-01","conditions":"Cardiac Surgery, Low Ejection Fraction","enrollment":240},{"nctId":"NCT03541603","phase":"PHASE2","title":"Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF","status":"COMPLETED","sponsor":"Tenax Therapeutics, Inc.","startDate":"2018-11-14","conditions":"Hypertension Pulmonary Secondary, Heart Failure, Right Sided, Heart Failure With Normal Ejection Fraction","enrollment":44},{"nctId":"NCT02232399","phase":"PHASE2","title":"Is Levosimendan Superior to Milrinone Regarding Acute Kidney Injury After Cardiac Surgery for Congenital Heart Disease?","status":"COMPLETED","sponsor":"Göteborg University","startDate":"2014-10-15","conditions":"Congenital Heart Defects","enrollment":72},{"nctId":"NCT04330755","phase":"PHASE4","title":"Levosimendan Versus Combination With Magnesium Sulphate on Spine Protection by NIRS in Infants Undergoing Coarctectomy","status":"COMPLETED","sponsor":"Dalia Saad Abd-El Kader","startDate":"2021-02-04","conditions":"Aortic Coarctation","enrollment":40},{"nctId":"NCT06021587","phase":"","title":"Interest of Levosimendan Preconditioning for Cardiac Surgery Under CEC in Heart Failure Patients With Impaired Ejection Fraction","status":"UNKNOWN","sponsor":"Central Hospital, Nancy, France","startDate":"2023-07-01","conditions":"Levosimendan, Cardiac Surgery, Heart Failure With Reduced Ejection Fraction","enrollment":300},{"nctId":"NCT05956431","phase":"PHASE4","title":"RCT Study of Levosimendan Improving Prognosis of Cardiac Arrest","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2023-08-01","conditions":"Heart Arrest","enrollment":60},{"nctId":"NCT05233202","phase":"PHASE3","title":"Levosimendan Versus Placebo Before Tricuspid Valve Surgery in Patients With Right Ventricular Dysfunction","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-01-23","conditions":"Patients Referred for an Isolated or a Combined Surgical Correction of Functional Moderate to Severe Tricuspid","enrollment":230},{"nctId":"NCT05658692","phase":"PHASE4","title":"Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2022-10-01","conditions":"Acute Respiratory Distress Syndrome","enrollment":1000},{"nctId":"NCT03022877","phase":"NA","title":"Acute and Chronic Protective Effects of Peri-interventional Administration of Levosimendan in ST Elevation Myocardial Infarctions","status":"WITHDRAWN","sponsor":"RWTH Aachen University","startDate":"2017-06","conditions":"Myocardial Infarction, Outcome","enrollment":""},{"nctId":"NCT05063370","phase":"PHASE2","title":"Levosimendan in Patients With Impaired Right Ventricular Function Undergoing Cardiac Surgery","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2021-08-18","conditions":"Right Heart Failure, Open-heart Surgery","enrollment":40},{"nctId":"NCT04970238","phase":"PHASE4","title":"Effect of Levosimendan on Left Ventricular Systolic Function and Heart Failure After PCI in Patients With Acute Anterior Myocardial Infarction","status":"UNKNOWN","sponsor":"Zhijun Sun","startDate":"2021-10","conditions":"ST Elevation Myocardial Infarction, Heart Failure","enrollment":500},{"nctId":"NCT04950569","phase":"PHASE4","title":"Effect of Levosimendan on miRNAs Regulation in the Failing Hearts","status":"UNKNOWN","sponsor":"Tongji Hospital","startDate":"2020-10-29","conditions":"Heart Failure","enrollment":136},{"nctId":"NCT04917497","phase":"","title":"Levosimendan Infusion in Critically Ill Patients With Cardiogenic Shock","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2011-06-30","conditions":"Cardiogenic Shock, Cardiorenal Syndrome, Acute Kidney Failure","enrollment":43},{"nctId":"NCT02531724","phase":"PHASE4","title":"Effects of Levosimendan in Acute Kidney Injury After Cardiac Surgery","status":"COMPLETED","sponsor":"Sahlgrenska University Hospital","startDate":"2015-09","conditions":"Acute Kidney Injury, Renal Insufficiency, Acute","enrollment":30},{"nctId":"NCT03699215","phase":"PHASE3","title":"Clinical Trial in Patients Who Have Suffered a Heart Attack and Who Have Undergone Catheterization Treated With Levosimendan","status":"UNKNOWN","sponsor":"Hospital Universitario de Canarias","startDate":"2018-11-17","conditions":"ST Elevation Myocardial Infarction","enrollment":184},{"nctId":"NCT04635293","phase":"NA","title":"Preoperative Infusion of Levosimendan in Patients Undergoing Cardiac Surgery","status":"COMPLETED","sponsor":"Aretaieion University Hospital","startDate":"2012-01-01","conditions":"Cardiac Disease, Cardiac Failure, Cardiac Surgery","enrollment":100},{"nctId":"NCT04573049","phase":"PHASE4","title":"The Effectiveness and Safety of Levosimendan in Patients With Severe Aortic Stenosis and Heart Failure Undergoing Transcatheter Aortic Valve Replacement","status":"UNKNOWN","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2020-09-01","conditions":"Aortic Valve Stenosis, Heart Failure, Inotropic Agents","enrollment":124},{"nctId":"NCT04179604","phase":"PHASE2, PHASE3","title":"Spanish Randomized Clinical Trial to Compare Levosimendan Versus Placebo in Postoperative Cardiac Surgery (SPARTANS)","status":"UNKNOWN","sponsor":"María de los Ángeles Tena Pajuelo","startDate":"2020-06-17","conditions":"Cardiac Output, Low","enrollment":300},{"nctId":"NCT02133105","phase":"PHASE3","title":"Levosimendan Versus Dobutamine for Renal Function in Heart Failure","status":"COMPLETED","sponsor":"Göteborg University","startDate":"2014-04","conditions":"Cardiorenal Syndrome","enrollment":33},{"nctId":"NCT02972918","phase":"","title":"Preoperative levosimendán and Hip Fracture","status":"COMPLETED","sponsor":"Hospital Universitario de Canarias","startDate":"2014-05","conditions":"Ventricular Dysfunction, Left, Hip Fracture","enrollment":19},{"nctId":"NCT01500785","phase":"PHASE4","title":"Intracoronary Administration of Levosimendan in Cardiac Surgery Patients","status":"TERMINATED","sponsor":"Tampere University Hospital","startDate":"2018-06-15","conditions":"Myocardial Stunning","enrollment":50},{"nctId":"NCT03576677","phase":"PHASE4","title":"Effect of Levosimendan or Placebo on Exercise in Advanced Chronic Heart Failure","status":"UNKNOWN","sponsor":"Finn Gustafsson","startDate":"2019-08-01","conditions":"Heart Failure","enrollment":42},{"nctId":"NCT01318460","phase":"PHASE4","title":"Prophylactic Administration of Levosimendan in Patients Undergoing Coronary Surgery","status":"COMPLETED","sponsor":"AHEPA University Hospital","startDate":"2011-03","conditions":"Coronary Artery Disease","enrollment":32},{"nctId":"NCT03855579","phase":"PHASE4","title":"Levosimendan Versus Milrinone in Off Pump CABG Surgery","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2019-03-06","conditions":"Hemodynamics","enrollment":60},{"nctId":"NCT03764722","phase":"PHASE4","title":"Effectiveness of a Repetitive Use of 24-hour Levosimendan Infusions in Patients With Severe Systolic Heart Failure in Order to Prevent Rehospitalizations","status":"UNKNOWN","sponsor":"Collegium Medicum w Bydgoszczy","startDate":"2018-08-01","conditions":"Systolic Heart Failure","enrollment":100},{"nctId":"NCT01188369","phase":"PHASE4","title":"Effects of Levosimendan in Patients Eligible for Aortic Valve Replacement With Left Ventricular Hypertrophy","status":"TERMINATED","sponsor":"University of Aarhus","startDate":"2010-09","conditions":"Diastolic Dysfunction, Left Ventricular Hypertrophy","enrollment":20},{"nctId":"NCT03437226","phase":"PHASE3","title":"Repetitive Levosimendan Infusion for Patients With Advanced Chronic Heart Failure","status":"UNKNOWN","sponsor":"Dr. Gerhard Pölzl","startDate":"2018-03-08","conditions":"Heart Failure","enrollment":264},{"nctId":"NCT02141607","phase":"","title":"Evolution of Molecular Biomarkers in Acute Heart Failure Induced by Shock","status":"COMPLETED","sponsor":"Shockomics Consortium","startDate":"2014-10","conditions":"Acute Heart Failure, Shock","enrollment":70},{"nctId":"NCT03557255","phase":"PHASE2","title":"Levosimendan for Cardiac Patients Undergoing Major Abdominal Cancer Surgeries","status":"COMPLETED","sponsor":"National Cancer Institute, Egypt","startDate":"2017-08-01","conditions":"Heart Failure","enrollment":60},{"nctId":"NCT02973620","phase":"","title":"Levosimendan Compassionate Use in Pediatric Patients With Advanced Decompensated Heart Failure","status":"NO_LONGER_AVAILABLE","sponsor":"Tenax Therapeutics, Inc.","startDate":"","conditions":"Heart Decompensation","enrollment":""},{"nctId":"NCT01290146","phase":"PHASE3","title":"ELEVATE Early LEvosimendan Vs Usual Care in Advanced Chronic hearT failurE","status":"TERMINATED","sponsor":"Niguarda Hospital","startDate":"2011-02","conditions":"Advanced Chronic Heart Failure","enrollment":13},{"nctId":"NCT02184819","phase":"PHASE3","title":"Preoperative Levosimendan in CABG Patients With Poor LV Function","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2013-06","conditions":"Coronary Artery Bypass Grafting, Left Ventricular Dysfonction","enrollment":335},{"nctId":"NCT01536132","phase":"PHASE4","title":"Intermittent Intravenous Levosimendan in Ambulatory Advanced Chronic Heart Failure Patients","status":"COMPLETED","sponsor":"Parc de Salut Mar","startDate":"2010-04","conditions":"Heart Failure","enrollment":70},{"nctId":"NCT02261948","phase":"PHASE4","title":"Levosimendan Efficacy Assessment by Cardiopulmonary Exercise Test (CPET)","status":"COMPLETED","sponsor":"Centro Cardiologico Monzino","startDate":"2012-09","conditions":"Heart Failure","enrollment":42},{"nctId":"NCT01969071","phase":"PHASE4","title":"The Effects of Levosimendan During Mitral Valve Surgery","status":"COMPLETED","sponsor":"Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital","startDate":"2009-07","conditions":"Mitral Valve Stenosis With Incompetence or Regurgitation","enrollment":140},{"nctId":"NCT00988806","phase":"PHASE4","title":"Long-Term Intermittent Administration of Levosimendan in Patients With Advanced Heart Failure","status":"UNKNOWN","sponsor":"Hospital Universitario de Canarias","startDate":"2009-11","conditions":"Advanced Heart Failure","enrollment":213},{"nctId":"NCT00585104","phase":"PHASE2","title":"Myocardial Hemodynamic Effects of Levosimendan","status":"COMPLETED","sponsor":"University of Utah","startDate":"2006-09","conditions":"Heart Failure","enrollment":10},{"nctId":"NCT01022983","phase":"PHASE4","title":"Preoperative Levosimendan and Heart Failure","status":"WITHDRAWN","sponsor":"Sykehuset i Vestfold HF","startDate":"2011-04","conditions":"Heart Failure, Hip Fracture","enrollment":""},{"nctId":"NCT01120106","phase":"PHASE2","title":"Levosimendan Administration in Neonates With Transposition of the Great Arteries","status":"COMPLETED","sponsor":"Bambino Gesù Hospital and Research Institute","startDate":"2009-01","conditions":"Low Cardiac Output Syndrome","enrollment":63},{"nctId":"NCT00324766","phase":"PHASE4","title":"Levosimendan in Acute Heart Failure Following Acute Myocardial Infarction.","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2006-06","conditions":"Myocardial Infarction, Heart Failure, Cardiogenic Shock","enrollment":61},{"nctId":"NCT01576094","phase":"PHASE1, PHASE2","title":"Two Inodilators Postsurgery in Neonates","status":"COMPLETED","sponsor":"Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz","startDate":"2009-11","conditions":"Low Cardiac Output Syndrome","enrollment":20},{"nctId":"NCT01210976","phase":"PHASE4","title":"The Effects of Levosimendan on Haemodynamics in Patients Undergoing Elective Aortic Valve Replacement (AVR)Together With Coronary Artery Bypass Grafting (CABG) Surgery","status":"COMPLETED","sponsor":"Tampere University Hospital","startDate":"2009-01","conditions":"Heart Valve Disease","enrollment":24},{"nctId":"NCT01065194","phase":"PHASE3","title":"Efficacy and Safety of Pulsed Infusions of Levosimendan in Outpatients With Advanced Heart Failure","status":"UNKNOWN","sponsor":"Medical University Innsbruck","startDate":"2009-08","conditions":"Chronic Stable Heart Failure","enrollment":120},{"nctId":"NCT00800306","phase":"PHASE2","title":"Effects of Levosimendan on Microcirculation in Septic Shock","status":"COMPLETED","sponsor":"University of Roma La Sapienza","startDate":"2007-11","conditions":"Septic Shock","enrollment":40},{"nctId":"NCT00154115","phase":"PHASE4","title":"Levosimendan in High Risk Heart Valve Surgery","status":"COMPLETED","sponsor":"Kuopio University Hospital","startDate":"2005-03","conditions":"Heart Failure","enrollment":200},{"nctId":"NCT00527059","phase":"PHASE4","title":"Renal Effects of Levosimendan in Patients Admitted With Acute Decompensated Heart Failure","status":"UNKNOWN","sponsor":"University of Roma La Sapienza","startDate":"2007-10","conditions":"Heart Failure, Renal Insufficiency","enrollment":21}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":165,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Levosimendan infusion","genericName":"Levosimendan infusion","companyName":"AHEPA University Hospital","companyId":"ahepa-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Levosimendan is a calcium sensitizer that increases the force of cardiac muscle contraction without increasing oxygen consumption, while also causing vasodilation through opening of ATP-sensitive potassium channels. Used for Acute decompensated heart failure.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}